Description

2-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-n-(4-Fluorophenyl)Acetamide is a high-purity, specialized purine derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical building block or intermediate for synthesizing novel therapeutic agents, particularly those targeting specific enzyme pathways. It is primarily needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in drug discovery programs. The compound, identified by CAS NO 332117-20-1, is supplied with stringent quality control to ensure reliability and reproducibility in sensitive applications.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential adenosine receptor antagonists or related purine-based drug candidates.
• Biochemical Research: Used as a reference standard or probe in enzymatic studies and mechanism-of-action research.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity.
• Preclinical Development: Supplied in development quantities for formulation studies and early-stage toxicology assessments.
• Academic Research: Utilized in university and institutional labs for fundamental research in chemical biology and pharmacology.
• Custom Synthesis: Starting material for the contract manufacturing of more complex, target-specific molecules.

Basic Information

Product Name	2-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-n-(4-Fluorophenyl)Acetamide
CAS No.	332117-20-1
Molecular Formula	C15H14FN5O3
Molecular Weight	331.31 g/mol
Synonyms	7H-Purine-7-acetamide, N-(4-fluorophenyl)-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-; 1,3-Dimethyl-7-[2-[(4-fluorophenyl)amino]-2-oxoethyl]-3,7-dihydro-1H-purine-2,6-dione; 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-fluorophenyl)acetamide; 332117-20-1; 4-Fluoro-N-[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]aniline; Purine derivative 332117-20-1; N-(4-Fluorophenyl)-2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetamide
EINECS	Contact for details

Quality Control

Our 2-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-n-(4-Fluorophenyl)Acetamide is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) with detailed chromatographic data are provided for full traceability and lot-to-lot consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.